中国实用外科杂志

• 专题笔谈 • 上一篇    下一篇

急性肺栓塞诊断和治疗

杨心蕊叶开创陆信武   

  1. 上海交通大学医学院附属第九人民医院血管外科 上海交通大学血管病诊治中心,上海 200011
  • 出版日期:2020-12-01 发布日期:2020-12-21

  • Online:2020-12-01 Published:2020-12-21

摘要: 急性肺栓塞发病率高,症状的不典型性容易引起误诊。诊断和危险分层决定了急性肺栓塞的治疗策略。抗凝和系统性溶栓是几十年来的主要的治疗选择,腔内介入技术越来越多地应用于急性肺栓塞的治疗中。尤其对于存在出血风险的病人,可能可以达到降低病人的总体风险,改善预后的作用。仍需要大规模高质量研究数据提供更多临床证据完善相关诊疗方案。

关键词: 急性肺栓塞, 危险分层, 抗凝, 溶栓, 腔内治疗

Abstract: Diagnosis and management of acute pulmonary embolism         YANG Xin-rui,YE Kai-chuang,LU Xin-wu. Department of Vascular Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine;Vascular Center of Shanghai Jiaotong University, Shanghai 200011,China
Corresponding author:LU Xin-wu,E-mail:luxinwu@aliyun.com
Abstract    The incidence of acute pulmonary embolism is high,and the atypical symptoms are easy to cause misdiagnosis.Diagnosis and risk stratification determine the treatment strategy for acute pulmonary embolism.Anticoagulation and systemic thrombolysis have been the main treatment options for decades,and endovascular techniques have been increasingly used in the treatment of acute pulmonary embolism.Especially for patients with bleeding risk,it may reduce the overall risk of patients and improve the prognosis.Better protocols and treatment algorithms that are derived from sound,large-scale randomized clinical trials will be crucial.

Key words: acute pulmonary embolism, risk stratification, anticoagulation, thrombolysis, endovascular treatment